Treatment of recurrent hepatocellular carcinoma: The current standards and future perspectives

doi:10.4251/wjgo.v17.i11.110735

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (17)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series.

Item

Count

PDF

HTML

Figures (1-2)

Sum=13

Nov 15, 2025 (publication date) through Nov 13, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Oncol. Nov 15, 2025; 17(11): 110735
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.110735

Open in New Tab Full Size Figure Download Figure

Figure 1 Schematic illustration of locoregional therapies for hepatocellular carcinoma[29]. CT: Computed tomography. Citation: Criss CR, Makary MS. Salvage locoregional therapies for recurrent hepatocellular carcinoma. World J Gastroenterol 2023; 29: 413-424. Copyright© The Authors 2023. Published by Baishideng Publishing Group.

Open in New Tab Full Size Figure Download Figure

Figure 2 Proposed algorithm for management of recurrent hepatocellular carcinoma. RHCC: Recurrent hepatocellular carcinoma; CTP: Child-Turcotte-Pugh; MELD: Model for end-stage liver disease; BCLC: Barcelona Clinic Liver Cancer; Tx: Transplant; BSC: Best supportive care; PV: Portal vein; TACE: Transcatheter arterial chemoembolization.

Citation: Elsayed MOK. Treatment of recurrent hepatocellular carcinoma: The current standards and future perspectives. World J Gastrointest Oncol 2025; 17(11): 110735
URL: https://www.wjgnet.com/1948-5204/full/v17/i11/110735.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i11.110735